uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
[Time to revise guidelines concerning anticoagulants in atrial fibrillation]
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Medical Sciences. (Akut- och internmedicin)
2002 (Swedish)In: Lakartidningen, ISSN 0023-7205, Vol. 99, no 44, 4375-7 p.Article in journal (Other scientific) Published
Place, publisher, year, edition, pages
2002. Vol. 99, no 44, 4375-7 p.
Keyword [en]
Aged, Anticoagulants/adverse effects/contraindications/*therapeutic use, Atrial Fibrillation/complications/*drug therapy, Cerebral Hemorrhage/chemically induced, Decision Making, Fatal Outcome, Female, Humans, Male, Practice Guidelines, Primary Prevention, Warfarin/adverse effects
Identifiers
URN: urn:nbn:se:uu:diva-73325PubMedID: 12469584OAI: oai:DiVA.org:uu-73325DiVA: diva2:101235
Available from: 2005-06-02 Created: 2005-06-02 Last updated: 2011-01-13

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12469584&dopt=Citation
By organisation
Department of Medical Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 519 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf